|
|
|
27.12.25 - 19:45
|
Senvest Capital Inc. Announces Death of Chief Executive Officer and Chairman of the Board (GlobeNewswire EN)
|
|
|
MONTREAL, Dec. 27, 2025 (GLOBE NEWSWIRE) -- Senvest Capital Inc. (the “Corporation” or “Senvest”) (TSX: SEC) announces with profound sadness the passing of its founder and long-time leader, Victor Mashaal, who served as President, Chief Executive Officer, and Chairman of the Board of Directors. Victor passed away at the age of 87 following a brief illness. He was a deeply respected and admired leader and a mentor to the entire Senvest family. He will be greatly missed....
|
|
|
27.12.25 - 00:00
|
MEDIROM Partners with World (GlobeNewswire EN)
|
|
|
Deploying “Proof of Human” Infrastructure throughout Japan, a Technology Envisioned by Sam Altman and Alex Blania Deploying “Proof of Human” Infrastructure throughout Japan, a Technology Envisioned by Sam Altman and Alex Blania...
|
|
|
26.12.25 - 23:45
|
Southpoint holdings in Fennec Pharmaceuticals Inc. (TSX: FENC) (GlobeNewswire EN)
|
|
|
NEW YORK, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Southpoint Capital Advisors LP (“Southpoint”), acting on behalf of certain Southpoint funds for which it serves as investment manager, announces that on December 24, 2025, pursuant to securities laws, it disposed of beneficial ownership of 1,000,000 common shares (a “Common Share”) of Fennec Pharmaceuticals Inc. (“Fennec”), representing approximately 2.93% of the outstanding Common Shares (calculated on a fully diluted basis)....
|
|
|
26.12.25 - 23:03
|
Outlook Therapeutics Announces New Employment Inducement Grants (GlobeNewswire EN)
|
|
|
ISELIN, N.J., Dec. 26, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that effective December 19, 2025, the Outlook Therapeutics, Inc. Compensation Committee of the Board of Directors granted stock options to purchase an aggregate of 150,000 shares of Outlook Therapeutics common stock with a per share exercise price of $2.01 per share to two new employees....
|
|
|
|
|
26.12.25 - 22:18
|
Cycurion, Inc. (NASDAQ: CYCU) Announces Corrected Dividend Distribution Ratio of 0.0080 in Connection with its Previously Announced $500,000 Common Share Dividend (GlobeNewswire EN)
|
|
|
MCLEAN, Va., Dec. 26, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU) (“Cycurion” or the “Company”) refers to the press release dated December 11, 2026, in which the Company announced a dividend distribution ratio of 0.0180 in connection with the previously announced pro-rata distribution of approximately $500,000 of CYCU shares to its own shareholders (on a fully diluted basis). Cycurion today announces a corrected dividend distribution ratio of 0.0080, which takes into consideration the common shares issuable upon the exercise of the Company's warrants that were issued in connection with the previously announced private placement that closed on December 5, 2025. Except for the correction described above, all other terms and conditions of the dividend remain unchanged....
|
|
|
|
|
26.12.25 - 20:00
|
Fitell Corporation Announces Interim Dividend and Shareholder Loyalty Program (GlobeNewswire EN)
|
|
|
Taren Point, Australia, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Fitell Corporation (NASDAQ: FTEL) (“Fitell” or the “Company”) announced its board of directors (the “Boards”) of the Company has declared two initiatives – an interim dividend and a one-time shareholder loyalty program – both designed to return value to shareholders and enhance long-term investor alignment with the Company's evolving growth strategy....
|
|
|
|
|
|
|
|
|
|
|
|
|
26.12.25 - 14:48
|
Nexxen Announces Updates to 2025 Annual General Meeting Proposals (GlobeNewswire EN)
|
|
|
NEW YORK, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and advanced TV, today announced that it has published a Supplemental Proxy Statement in connection with its 2025 Annual General Meeting of Shareholders scheduled for December 30, 2025 (the “AGM”)....
|
|
|
|
|
|
|
26.12.25 - 14:33
|
TechForce Robotics to Exhibit at CES 2026, Showcasing Full Portfolio of Proprietary Robotics Technologies and Accepting Customer Orders (GlobeNewswire EN)
|
|
|
LOS ANGELES, Dec. 26, 2025 (GLOBE NEWSWIRE) -- via IBN -- Nightfood Holdings, Inc. dba TechForce Robotics (OTCQB: NGTF) (“TechForce” or the “Company”), an AI-driven service-robotics platform focused on hospitality, foodservice, and commercial automation, announces its participation at CES® 2026, taking place January 6–9, in Las Vegas, Nevada. Attendees are invited to visit TechForce Robotics at CES 2026 at Booth 6911 to experience live demonstrations and speak with the Company's team about product capabilities, deployment options, and ordering opportunities....
|
|
|
|
|
|
|
26.12.25 - 14:03
|
Arcadia Biosciences (RKDA) Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources (GlobeNewswire EN)
|
|
|
DALLAS, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today announced that on December 24, 2025, it received a notice from Roosevelt Resources, LP, terminating the Securities Exchange Agreement between Arcadia and Roosevelt dated December 4, 2024, pursuant to the terms of the agreement. The agreement provided for a proposed business combination transaction between the two companies....
|
|